TXMD - TherapeuticsMD, Inc.
2.3
0 0%
Share volume: 36,274
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$2.30
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-12-2024 | 11-12-2024 | 03-27-2025 | 05-13-2025 | 08-12-2025 | 11-12-2025 | |
| Total revenue | 313.000 K | 234.000 K | 547.000 K | 667.000 K | 393.000 K | 952.000 K | 784.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 313.000 K | 234.000 K | 547.000 K | 667.000 K | 393.000 K | 952.000 K | 784.000 K | |
| -25.24% | 133.76% | 21.94% | -41.08% | 142.24% | -17.65% | |||
| Operating expenses | 1.322 M | 1.233 M | 1.310 M | 879.000 K | 1.081 M | 1.551 M | 1.518 M | |
| Selling general and admin | 1.322 M | 1.233 M | 1.310 M | 879.000 K | 1.081 M | 1.551 M | 1.518 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 1.455 M | 2.674 M | 1.406 M | 986.000 K | 1.264 M | 1.647 M | 1.646 M | |
| 83.78% | -47.42% | -29.87% | 28.19% | 30.30% | -0.06% | |||
| Operating income | -1.142 M | -2.440 M | -859.000 K | -319.000 K | -871.000 K | -695.000 K | -862.000 K | |
| Ebit | -809.000 K | -1.045 M | -564.000 K | 75.000 K | -666.000 K | 171.000 K | -481.000 K | |
| Pretax income | -809.000 K | -1.050 M | -567.000 K | 83.000 K | -668.000 K | 545.000 K | 50.000 K | |
| 29.79% | -46.00% | -114.64% | -904.82% | -181.59% | -90.83% | |||
| Income tax | 0.000 | 0.000 | 0.000 | -31.000 K | -32.000 K | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -734.000 K | -1.090 M | -609.000 K | 252.000 K | -653.000 K | 551.000 K | 152.000 K | |
| -48.50% | 44.13% | 141.38% | -359.13% | 184.38% | -72.41% |